SG11201702354TA - Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor - Google Patents

Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor

Info

Publication number
SG11201702354TA
SG11201702354TA SG11201702354TA SG11201702354TA SG11201702354TA SG 11201702354T A SG11201702354T A SG 11201702354TA SG 11201702354T A SG11201702354T A SG 11201702354TA SG 11201702354T A SG11201702354T A SG 11201702354TA SG 11201702354T A SG11201702354T A SG 11201702354TA
Authority
SG
Singapore
Prior art keywords
renal insufficiency
inhibitor
prophylactic agent
indoxyl sulfate
sulfate production
Prior art date
Application number
SG11201702354TA
Inventor
Ayaka Nakashima
Yuta Asayama
Osamu Iwata
Kengo Suzuki
Original Assignee
Euglena Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euglena Co Ltd filed Critical Euglena Co Ltd
Publication of SG11201702354TA publication Critical patent/SG11201702354TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201702354TA 2014-09-29 2015-09-29 Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor SG11201702354TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014199433 2014-09-29
PCT/JP2015/077523 WO2016052509A1 (en) 2014-09-29 2015-09-29 Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor

Publications (1)

Publication Number Publication Date
SG11201702354TA true SG11201702354TA (en) 2017-05-30

Family

ID=55630536

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201702354TA SG11201702354TA (en) 2014-09-29 2015-09-29 Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor

Country Status (7)

Country Link
US (1) US10231989B2 (en)
JP (1) JPWO2016052509A1 (en)
KR (1) KR20170053723A (en)
CN (1) CN107073032B (en)
MY (1) MY187270A (en)
SG (1) SG11201702354TA (en)
WO (1) WO2016052509A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019117654A1 (en) * 2017-12-15 2019-06-20 (주)녹십자웰빙 Probiotics for inhibiting and preventing progression of renal diseases, and compositions for inhibiting and preventing progression of renal diseases comprising same
JP6996460B2 (en) * 2018-09-10 2022-01-17 国立大学法人 熊本大学 Inhibitors, prophylaxis, and treatments for the progression of kidney disease
KR102083165B1 (en) * 2019-09-18 2020-03-02 대상 주식회사 Novel microorganism of the Genus Euglena having beta-1,3-glucan-producing activity and process for producing Euglena-biomass containing beta-1,3-glucan using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274002B (en) 1994-11-14 1997-07-14 Isi Ist Sierovaccinogeno Ital USE OF POLYMERIC SUBSTANCES AND COMPOSITIONS FOR THE TREATMENT OF UREMIA THROUGH THE CONTROL OF TOXIC AND / OR DIPSOGENIC FACTORS AND OF THE HYDROCOSALINE BALANCE
DE59901613D1 (en) 1999-02-10 2002-07-11 Suwelack Skin & Health Care Ag Freeze-dried product containing Euglena beta-1,3-glucan, its manufacture and use
US20040197352A1 (en) 1999-04-30 2004-10-07 Natarajan Ranganathan Methods of improving or augmenting kidney function
CA2540467C (en) * 2003-09-30 2013-11-12 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
JP2006273772A (en) 2005-03-30 2006-10-12 Japan Organo Co Ltd Orally administered drug and method for producing the same
JP4305785B1 (en) 2008-10-15 2009-07-29 森永製菓株式会社 Purine absorption inhibitor and blood uric acid level reducing agent
JP5612875B2 (en) 2010-03-09 2014-10-22 株式会社ユーグレナ Type 1 or type 4 hypersensitivity allergy symptoms inhibitor or type 1 hypersensitivity allergy symptoms inhibitor
JP2014024817A (en) 2012-07-30 2014-02-06 Nippon Kayaku Food Techno Kk Preventive or therapeutic agent for chronic renal failure
JP2014118374A (en) * 2012-12-14 2014-06-30 Euglena Co Ltd Diabetes inhibitor

Also Published As

Publication number Publication date
CN107073032B (en) 2020-12-22
JPWO2016052509A1 (en) 2017-06-08
US20170224717A1 (en) 2017-08-10
US10231989B2 (en) 2019-03-19
KR20170053723A (en) 2017-05-16
CN107073032A (en) 2017-08-18
MY187270A (en) 2021-09-17
WO2016052509A1 (en) 2016-04-07

Similar Documents

Publication Publication Date Title
IL304491A (en) Methods for reducing cardiovascular risk
GB201421716D0 (en) Cell expansion procedure
EP3174832A4 (en) Methods for treating premise plumbing
PL3097165T3 (en) High efficiency pour point reduction process
HUE042244T2 (en) Method for the operation and expansion of a network of lights
HK1215898A1 (en) Network energy consumption reduction
EP3170571A4 (en) Pipe expander
DK3510007T3 (en) [18f]-mærket lactatderivativ som pet-radiotracer
AU361940S (en) Pipe fitting
GB201408606D0 (en) Audio mode selector
GB2556723B (en) Pipe fitting
SG11201702354TA (en) Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor
PL3191222T3 (en) Coating slurry
EP3203839A4 (en) Alkanolamine sulfate water conditioners
GB201507402D0 (en) Pipe Forming Method
GB2545470B (en) Plumbing fixtures
GB2555726B (en) Urea production method
IL247837A0 (en) Methods for reducing cardiovascular risk
PT3166397T (en) Delayed reactivity quicklime, process for manufacturing same and use thereof
GB201509677D0 (en) Manufacturing process for polysaccharide beads
PL3036032T3 (en) Method for the production of concentrates, preferably of water-soluble agents
GB201402787D0 (en) Expansion method
GB201402786D0 (en) Expansion method
GB201410179D0 (en) Anti-ligature fixtures
ZA201606729B (en) Coupled pipeline